Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis

Journal of Research in Medical Sciences

Volumn 17, Issue 9, 2012, Pages 872-875

  Scicchitano, Francesca ^a,b   Giofrè, Chiara ^a,b   Palleria, Caterina ^a,b   Mazzitello, Carmela ^a,b   Ciriaco, Miriam ^a,b   Gallelli, Luca ^a,b   Paletta, Laura ^a,b   Marrazzo, Giuseppina ^a,b   de Fazio, Salvatore ^a,b   Menniti, Michele ^a,b   Curia, Rubens ^c   Arena, Concetta ^c   Chimirri, Serafina ^a,b   Patanè, Marinella ^a,b   Esposito, Stefania ^a,b   Cilurzo, Felisa ^a,b   Staltari, Orietta ^a,b   Russo, Emilio ^a,b   de Sarro, Giovambattista ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Policlinico Mater Domini   (Italy)

^c Department of health and health politics ^*  (Italy)

Author keywords

Adverse drug reaction reporting systems; Adverse effects; Calabria; Drug toxicity; Italy; Pharmacovigilance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANTIULCER AGENT; CONTRAST MEDIUM; KETOPROFEN; NEUROLEPTIC AGENT; OPIATE; VACCINE;

AGE; ARTICLE; DATA BASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GENDER; HOSPITAL PHYSICIAN; HUMAN; ITALY; MEDICAL SPECIALIST; PHARMACIST; QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT;

EID: 84869474404     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Jeetu G, Anusha G. Pharmacovigilance: A worldwide master key for drug safety monitoring. J Young Pharm 2010;2:315-20.
2. Schjøtt J, Reppe LA, Roland PD, Westergren T. A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): A descriptive study. BMJ Open 2012;2:e000642.
3. Benkirane RR, Abouqal R, Haimeur CC, EchCherif El Kettani SS, Azzouzi AA, MdaghriAlaoui AA, et al. Incidence of adverse drug events and medication errors in intensive care units: A prospective multicenter study. J Patient Saf 2009;5:16-22.
4. Napoleone E. Children and ADRs (Adverse Drug Reactions). Ital J Pediatr 2010;36:4.
5. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: A systematic review. Drug Saf 2009;32:19-31.
6. Conforti A, Opri S, D'Incau P, Sottosanti L, Moretti U, Ferrazin F, et al. Adverse drug reaction reporting by nurses: Analysis of Italian pharmacovigilance database. Pharmacoepidemiol Drug Saf 2012;21:597-602.
7. Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res 2011;2:129-36.
8. Su C, Ji H, Su Y. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf2010;19:217-22.
9. Kimura T, Matsushita Y, Yang YH, Choi NK, Park BJ. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan. Pharmacoepidemiol Drug Saf 2011;20:1237-45.
10. Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci 2011;16:16-25.
11. Available from: http://www.agenziafarmaco.gov.it/ Last accessed on 20 June 2012.